Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemiaChristina Rautenberg, Jan Moritz Middeke, Verena I. Gaidzik et al.|Blood Cancer Journal|2021Cited by 65
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia – long-term follow-up with focus on younger patientsChristina Rautenberg, Friedrich Stölzel, Jan Moritz Middeke et al.|Blood Cancer Journal|2025Cited by 6